Appendix C
Registered Attendees
Asa Abeliovich
Prevail Therapeutics
Amy Adams
National Institute of Neurological Disorders and Stroke
Andrew Adams
Eli Lilly and Company
Julie Adams
PPD Biotech
Diaa Ahmed
Utrecht University
Zeshan Ahmed
Eli Lilly and Company
Effie Albanis
Neurogene, Inc.
Robert Alexander
Takeda Pharmaceuticals
Reem Aljuhani
Georgetown University
Kathleen Anderson
National Institute of Mental Health
Megan Anderson Brooks
CRD Associates
Patrick Antonellis
Eli Lilly and Company
Irina Antonijevic
Wave Life Sciences
Mona Ashiya
OrbiMed
Nazem Atassi
Sanofi Genzyme
Shelli Avenevoli
National Institute of Mental Health
Jennifer Beierlein
National Science Foundation
Frank Bennett
Ionis Pharmaceuticals
Sangeeta Bhargava
National Eye Institute
Anuradha Bhattacharyya
PTC Therapeutics
Dominika Bielak
Queens College, The City University of New York
David Bleakman
Redpin Therapeutics
Antonello Bonci
National Institute on Drug Abuse
Carsten Bonnemann
National Institute of Neurological Disorders and Stroke
Lizbet Boroughs
Association of American Universities
Chris Boshoff
National Institute of Neurological Disorders and Stroke
Linda Brady
National Institute of Mental Health
David Bredt
Janssen R&D
Katja Brose
Chan Zuckerberg Initiative
Bob Brown
Dicerna Pharmaceuticals
Bettina Buhring
National Institute of Mental Health
Daniel Burch
PPD Biotech
Joseph Buxbaum
Icahn School of Medicine at Mount Sinai
Sarah Caddick
Thalamic
Rosa Canet-Aviles
Foundation for the National Institutes of Health
Mantej (Nimi) Chhina
BioMarin Pharmaceutical, Inc.
Lisa Chong
Science Magazine
Stephanie Ciarlone
PTC Therapeutics
Timothy Coetzee
National Multiple Sclerosis Society
Jonathan Cohen
Princeton University
Renee Corcoran
Axovant
Ronald Crystal
Weill Cornell Medicine
Bernard Dardzinski
Uniformed Services University of the Health Sciences
Beverly Davidson
Children’s Hospital of Philadelphia
University of Pennsylvania Perelman School of Medicine
Paula Demassi
Ministry of Public Health of Uruguay
Sarah DeVos
Denali Therapeutics
Jamie Driscoll
National Institute of Mental Health
Hank Dudek
Dicerna Pharmaceuticals
Lee Dudka
Dudka & Associates
Richard Esposito
U.S. Bureau of Labor Statistics
Keith Fargo
Alzheimer’s Association
Boris Feldman
Rite Aid Pharmacy
Boris Feldman
Wilson Sonsini Goodrich & Rosati
E’Lissa Flores
Milken Institute
Allyson Gage
Cohen Veterans Bioscience
Marcos Geovanini
PrevCor
Shaoqin Sarah Gong
University of Wisconsin–Madison
Joshua Gordon
National Institute of Mental Health
Viviana Gradinaru
California Institute of Technology
Julie Hagan
Apic Bio, Inc.
John Hall
IXICO
Chris Henderson
Biogen
Ross Henderson
CAREM, LLC
William Herring
Merck
Kevin Hibbert
Neurogene, Inc.
Ramona Hicks
One Mind
Mi Hillefors
National Institute of Mental Health
Richard Hodes
National Institute on Aging
Stuart Hoffman
Department of Veterans Affairs
Bruce Hope
National Institute on Drug Abuse
Nina Hsu
National Institutes of Health
Steven Hyman
The Broad Institute
Yoshimasa Ito
Eisai
Marcus Jackson
Queens College, The City University of New York
Anjana Jain
Food and Drug Administration
Frances Jensen
University of Pennsylvania Health System
Sophia Jeon
National Institute of Neurological Disorders and Stroke
Jeymohan Joseph
National Institute of Mental Health
Akiva Katz
University of Illinois College of Medicine Rockford
Petra Kaufmann
AveXis
Anastasia Khvorova
RNA Therapeutics Institute
University of Massachusetts Medical School
Sooja Kim
National Institutes of Health
Rune Kjeken
Norwegian Medicines Agency
Kelly Knopp
Eli Lilly and Company
Ying-Yee Kong
Department of Veterans Affairs
Jeffrey Kordower
Rush University Medical Center
Paul Korner
Axovant Gene Therapies
Walter Koroshetz
National Institute of Neurological Disorders and Stroke
Ana Kostic
Seaver Autism Center for Research & Treatment, Icahn School of Medicine at Mount Sinai
Robert Kotin
Generation Bio
University of Massachusetts Medical School
John Krystal
Yale University School of Medicine
Lina Kubli
Department of Veterans Affairs
Story Landis
National Institute of Neurological Disorders and Stroke
Larissa Lapteva
Food and Drug Administration
Timothy LaVaute
National Institute of Neurological Disorders and Stroke
Ernestine Lenteu
National Institute of Neurological Disorders and Stroke
Alan Leshner
American Association for the Advancement of Science
Liza Litvina
National Institute of Neurological Disorders and Stroke
Darya Litvinchuk
Apic Bio
David Litwack
Prevail Therapeutics
Laura Mamounas
National Institute of Neurological Disorders and Stroke
Glenn Mannheim
Food and Drug Administration
Janet Marchibroda
Bockorny Group
Peter Marks
Food and Drug Administration
Christine Marx
Duke University School of Medicine
Langston McKee
U.S. Agency for International Development
David McMullen
National Institutes of Health
Douglas Meinecke
National Institute of Mental Health
Fany Messanvi
National Institutes of Health
Mike Michaelides
National Institute on Drug Abuse
Enrique Michelotti
National Institute of Mental Health
Timothy Miller
PPD, Inc.
Yi Mo
Axovant Sciences
Jill Morris
National Institute of Neurological Disorders and Stroke
Jennifer Moser
Department of Veterans Affairs
Mattia Mroso
American Association for the Advancement of Science
Avindra Nath
National Institute of Neurological Disorders and Stroke
Rosie Stovell O’Donnell
Encoded Therapeutics
Steven Oh
Food and Drug Administration
Eileen O’Reilly
Axios
Michael Ortiz
Roivant Sciences
Maire Osborn
Dicerna Pharmaceuticals
Michael Panzara
Wave Life Sciences
Bryan Parker
International Healthcare
Tom Parry
Ovid Therapeutics
Creighton Phelps
National Institute on Aging
Keith Phillips
Eli Lilly and Company
Richard Podell
Unaffiliated
Nicole Polinski
The Michael J. Fox Foundation for Parkinson’s Research
Jenn Poole
Takeda Pharmaceuticals
Gabriele Proetzel
Takeda Pharmaceuticals
Ronald Przygodzki
Department of Veterans Affairs
Raj Puri
Food and Drug Administration
Sesquile Ramon
Biotechnology Innovation Organization
Elizabeth Ramsburg
Janssen Pharmaceuticals
Kathleen Reape
Spark Therapeutics
Barbara Redman
New York University
Lorenzo Refolo
National Institute on Aging
Lauren Reoma
National Institute of Neurological Disorders and Stroke
Lawrence Richards
American Psychological Association
Christopher Ricupero
Columbia University Medical Center
Becky Roof
National Institute of Neurological Disorders and Stroke
Erik Runko
National Science Foundation
Cristina Sampaio
CHDI Foundation
R. Jude Samulski
University of North Carolina at Chapel Hill
Eric Schaeffer
Janssen R&D
Tamera Schneider
National Science Foundation
Nina Schor
National Institute of Neurological Disorders and Stroke
Kelly Servick
Science Magazine
Douglas Sheeley
National Institute of Dental and Craniofacial Research
Chun-Pyn Shen
EMD Serono, Inc.
Lamya Shihabuddin
Sanofi
John Sims
Eli Lilly and Company
Anirudh Srirangam
Roivant Sciences
Michael Steinmetz
National Eye Institute
Junghae Suh
Rice University
James Sweet
Wilson Sonsini Goodrich & Rosati
Holly Tabor
Stanford University School of Medicine
Edmund Talley
National Institute of Neurological Disorders and Stroke
Amir Tamiz
National Institute of Neurological Disorders and Stroke
Hiroaki Tani
Eli Lilly and Company
Anderson Umah
Neolife Health International
Akshay Vaishnaw
Alnylam
Rita Valentino
National Institute on Drug Abuse
Rosaire Verna
Georgetown University
Christina Vert
National Institute of Neurological Disorders and Stroke
Jeannie Visootsak
Neurogene
Bhavya Voleti
Merck
Nora Volkow
National Institute on Drug Abuse
Hao Wang
Takeda Pharmaceuticals
Shiyu Wang
Dicerna Pharmaceuticals
Jackie Ward
National Institute of Neurological Disorders and Stroke
Andrew Welchman
Wellcome Trust
Pamella Williams
Health Services Authority
Doug Williamson
Lundbeck
Rachel Witten
Food and Drug Administration
Clinton Wright
National Institute of Neurological Disorders and Stroke
Rui Wu
MeiraGTx
Winifred Wu
Strategic Regulatory Partners, LLC
Yining Xie
National Institutes of Health
Li-chiung Yang
Unaffiliated
